Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes
Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
In pre-clinical mouse models, the interleukin-22 pathway is identified as a novel target for therapeutic intervention in metabolic diseases.
Metabolic diseases reversed by interleukin-22
Interleukin-22 (IL-22) promotes antimicrobial immunity and acts to maintain the integrity of the intestinal mucosal barrier. This study examines the connecti...
Alternative Titles
Full title
Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1610757834
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1610757834
Other Identifiers
ISSN
0028-0836
E-ISSN
1476-4687
DOI
10.1038/nature13564
